Premium
Letter: mechanistic target of rapamycin inhibitors—do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply
Author(s) -
Grigg Sam E.,
Sarri Gino L.,
Gow Paul J.,
Yeomans Neville D.
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15324
Subject(s) - liver transplantation , hepatocellular carcinoma , medicine , transplantation , carcinoma , milan criteria , oncology , gastroenterology